Brooks Automation GENEWIZ Acquisition 2018 Conference Call

Brooks Automation announces the acquisition of GENEWIZ Group for $450 million, a New Jersey-based genomic sequencing and synthesis company with global operations. GENEWIZ serves over 4,000 institutional customers in pharma and academic sectors with a differentiated delivery model across Sanger and Next-Gen Sequencing services.